QBIO — Q BioMed Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.25m
- $0.28m
Annual balance sheet for Q BioMed, fiscal year end - November 30th, USD millions except per share, conversion factor applied.
2018 November 30th | 2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 2.68 | 0.173 | 0.177 | 0.344 | 0.05 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | — | 0.08 | 0.012 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.7 | 0.19 | 0.223 | 0.459 | 0.072 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 3.2 | 0.64 | 0.623 | 0.809 | 3.52 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.429 | 5.24 | 1.7 | 5.49 | 8.13 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.3 | 5.69 | 1.7 | 5.49 | 8.13 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -0.106 | -5.05 | -1.08 | -4.69 | -4.62 |
| Total Liabilities & Shareholders' Equity | 3.2 | 0.64 | 0.623 | 0.809 | 3.52 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |